Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Eyal Dor"'
Autor:
Yani Berckmans, Hila M. Ene, Kerem Ben-Meir, Antonia Martinez-Conde, Roxanne Wouters, Bieke Van den Ende, Sara Van Mechelen, Roni Monin, Roni Frechtel-Gerzi, Hila Gabay, Eyal Dor-On, Adi Haber, Uri Weinberg, Ignace Vergote, Moshe Giladi, An Coosemans, Yoram Palti
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundOvarian cancer is the leading cause of mortality among gynecological malignancies. Carboplatin and poly (ADP-ribose) polymerase inhibitors (PARPi) are often implemented in the treatment of ovarian cancer. Homologous recombination deficient
Externí odkaz:
https://doaj.org/article/3e0b6e18f9dc4e9395f4d2768ea4274b
Autor:
Noam Cohen, Irit Simon, Ophir Hazan, Arnon Tal, Hanan Tzadok, Lilach Levin, Meni Girshengorn, Lilach Cherry Mimran, Niva Natan, Tzadok Baruhi, Alon Ben David, Osnat Rosen, Shlomo Shmaya, Sarah Borni, Noa Cohen, Edith Lupu, Adi Kedmi, Orian Zilberman, Avital Jayson, Arik Monash, Eyal Dor, Eran Diamant, Michael Goldvaser, Inbar Cohen-Gihon, Ofir Israeli, Shirley Lazar, Ohad Shifman, Adi Beth-Din, Anat Zvi, Ziv Oren, Arik Makovitzki, Elad Lerer, Avishai Mimran, Einat Toister, Ran Zichel, Yaakov Adar, Eyal Epstein
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
The COVID-19 pandemic has led to high global demand for vaccines to safeguard public health. To that end, our institute has developed a recombinant viral vector vaccine utilizing a modified vesicular stomatitis virus (VSV) construct, wherein the G pr
Externí odkaz:
https://doaj.org/article/decca5fe62ee475690287d8e70308a6f
Autor:
Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Lilach Levin, Meni Girshengorn, Niva Natan, Shira Chapman, Shlomo Shmaya, Eyal Epstein, Yaakov Adar, Ran Zichel, Yakir Ophir, Eran Diamant
Publikováno v:
Vaccines, Vol 12, Iss 4, p 374 (2024)
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than seven million deaths worldwide. To reduce viral spread, the Israel Institute for Biological Research (IIBR) developed and produce
Externí odkaz:
https://doaj.org/article/7396402146a4420489f34910524eb755
Autor:
Avraham Abutbul, Helena Mumblat, Yaara Porat, Nehemya Friedman, Nofar Atari, Shirley Sharabi, Ahmad Nama, Waseem Mugahed, Asa Kessler, Yotam Kolben, Reuben Ruby Shamir, Doron Manzur, Ori Farber, Liora Bosch, Gitit Lavy-Shahaf, Eyal Dor-On, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti, Yael Mardor, Michal Mandelboim
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Coronaviruses are the causative agents of several recent outbreaks, including the COVID-19 pandemic. One therapeutic approach is blocking viral binding to the host receptor. As binding largely depends on electrostatic interactions, we hypothesized po
Externí odkaz:
https://doaj.org/article/24eca6fa1c1b4314baa96b005a1eb007
Autor:
Ronit Rosenfeld, Ron Alcalay, Anat Zvi, Alon Ben-David, Tal Noy-Porat, Theodor Chitlaru, Eyal Epstein, Ofir Israeli, Shirley Lazar, Noa Caspi, Ada Barnea, Eyal Dor, Inbar Chomsky, Shani Pitel, Efi Makdasi, Ran Zichel, Ohad Mazor
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Hyper-immune antisera from large mammals, in particular horses, are routinely used for life-saving anti-intoxication intervention. While highly efficient, the use of these immunotherapeutics is complicated by possible recipient reactogenicity and lim
Externí odkaz:
https://doaj.org/article/30b19251d1ca439abe77d48d5514e1c8
Autor:
Ram Nechooshtan, Sharon Ehrlich, Marika Vitikainen, Arik Makovitzki, Eyal Dor, Hadar Marcus, Idan Hefetz, Shani Pitel, Marilyn Wiebe, Anne Huuskonen, Lilach Cherry, Edith Lupu, Yehuda Sapir, Tzvi Holtzman, Moshe Aftalion, David Gur, Hadas Tamir, Yfat Yahalom-Ronen, Yuval Ramot, Noam Kronfeld, David Zarling, Anne Vallerga, Ronen Tchelet, Abraham Nyska, Markku Saloheimo, Mark Emalfarb, Yakir Ophir
Publikováno v:
Vaccines, Vol 10, Iss 12, p 2119 (2022)
SARS-CoV-2 is evolving with increased transmission, host range, pathogenicity, and virulence. The original and mutant viruses escape host innate (Interferon) immunity and adaptive (Antibody) immunity, emphasizing unmet needs for high-yield, commercia
Externí odkaz:
https://doaj.org/article/8087098534aa48d98dd5ffae26105a5c
Autor:
Alon Ben David, Ada Barnea, Amram Torgeman, Eran Diamant, Eyal Dor, Arieh Schwartz, Osnat Rosen, Noa Caspi, Miki Saraf, Elad Lerer, Yaakov Adar, Edith Lupo, Einat Toister, Ran Zichel
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1522 (2022)
Botulism is a paralytic disease caused by botulinum neurotoxins (BoNTs). Equine antitoxin is currently the standard therapy for botulism in human. The preparation of equine antitoxin relies on the immunization of horses with botulinum toxoid, which s
Externí odkaz:
https://doaj.org/article/d1103dc01bdb44bdb659a7574f5ac830
Autor:
Eyal Dor, Tseela David, Hani Dekel Jaoui, Arieh Schwartz, Tzadok Baruchi, Amram Torgeman, Alon Ben David, Osnat Rosen, Arnon Tal, Amir Rosner, Ran Zichel, Eran Diamant
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Medical treatment may require the continuous intravenous (IV) infusion of drugs to sustain the therapeutic blood concentration and to minimize dosing errors. Animal disease models that ultimately mimic the intended use of new potential drugs via a co
Externí odkaz:
https://doaj.org/article/cbe9c813cba24e6bb358cde67db683ec
Autor:
Adva Mechaly, Eran Diamant, Ron Alcalay, Alon Ben David, Eyal Dor, Amram Torgeman, Ada Barnea, Meni Girshengorn, Lilach Levin, Eyal Epstein, Ariel Tennenhouse, Sarel J. Fleishman, Ran Zichel, Ohad Mazor
Publikováno v:
Antibodies, Vol 11, Iss 1, p 21 (2022)
Botulinum neurotoxin type E (BoNT/E), the fastest acting toxin of all BoNTs, cleaves the 25 kDa synaptosomal-associated protein (SNAP-25) in motor neurons, leading to flaccid paralysis. The specific detection and quantification of the BoNT/E-cleaved
Externí odkaz:
https://doaj.org/article/797ceaec67d04932a171fe9845595a57
Autor:
Arik Makovitzki, Avital Jayson, Ziv Oren, Elad Lerer, Yaron Kafri, Eyal Dor, Lilach Cherry, Hanan Tzadok, Lilach Levin, Ophir Hazan, Irit Simon, Arnon Tal, Meni Girshengorn, Osnat Rosen
Publikováno v:
BioTech, Vol 10, Iss 4, p 25 (2021)
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases the need for a rapid development of efficient vaccines. Among other vaccines in clinical trials, a recombinant VSV-∆G-spike vaccine was developed
Externí odkaz:
https://doaj.org/article/9fdb0f0bb6304d2198df94de3a3b3750